Steigerwald, Gordon & Koch Inc. Abbott Laboratories Transaction History

Steigerwald, Gordon & Koch Inc.

$884 Million
Q4 2024

A detailed history of Steigerwald, Gordon & Koch Inc. transactions in Abbott Laboratories stock. As of the latest transaction made, Steigerwald, Gordon & Koch Inc. holds 4,214 shares of ABT stock, worth $551,275. This represents 0.05% of its overall portfolio holdings.

Number of Shares

4,214

Previous 4,247 0.78%

Holding current value

$551,275

Previous $484,000 1.65%

% of portfolio

0.05%

Previous 0.05%

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Jan 16, 2025	SELL	$111.93 - $119.39 $3,693 - $3,939	-33 Reduced 0.78%	4,214 $476,000
Q3 2024 Oct 09, 2024	BUY	$100.07 - $118.13 $15,010 - $17,719	150 Added 3.66%	4,247 $484,000
Q2 2024 Aug 07, 2024	BUY	$100.73 - $112.44 $2,921 - $3,260	29 Added 0.71%	4,097 $425,000
Q1 2024 Apr 16, 2024	SELL	$109.52 - $120.96 $1,861 - $2,056	-17 Reduced 0.42%	4,068 $462,000
Q4 2023 Jan 16, 2024	BUY	$90.19 - $110.4 $6,764 - $8,280	75 Added 1.87%	4,085 $449,000
Q3 2023 Oct 11, 2023	BUY	$95.53 - $114.62 $57,126 - $68,542	598 Added 17.53%	4,010 $388,000
Q2 2023 Jul 17, 2023	BUY	$100.78 - $112.29 $12,899 - $14,373	128 Added 3.9%	3,412 $371,000
Q1 2023 Apr 19, 2023	BUY	$96.86 - $114.01 $5,617 - $6,612	58 Added 1.8%	3,284 $332,000
Q4 2022 Jan 17, 2023	BUY	$95.06 - $111.52 $18,631 - $21,857	196 Added 6.47%	3,226 $0
Q3 2022 Oct 12, 2022	BUY	$96.76 - $112.03 $1,451 - $1,680	15 Added 0.5%	3,030 $293,000
Q2 2022 Jul 14, 2022	SELL	$102.07 - $123.37 $6,328 - $7,648	-62 Reduced 2.01%	3,015 $328,000
Q1 2022 Apr 25, 2022	SELL	$114.02 - $139.04 $2,280 - $2,780	-20 Reduced 0.65%	3,077 $364,000
Q4 2021 Jan 26, 2022	BUY	$115.53 - $141.46 $25,416 - $31,121	220 Added 7.65%	3,097 $436,000
Q3 2021 Oct 18, 2021	BUY	$116.66 - $129.06 $6,182 - $6,840	53 Added 1.88%	2,877 $340,000
Q2 2021 Jul 27, 2021	BUY	$105.79 - $124.53 $740 - $871	7 Added 0.25%	2,824 $327,000
Q1 2021 Apr 27, 2021	BUY	$108.84 - $128.23 $4,571 - $5,385	42 Added 1.51%	2,817 $338,000
Q4 2020 Jan 22, 2021	BUY	$105.0 - $114.42 $5,460 - $5,949	52 Added 1.91%	2,775 $304,000
Q3 2020 Oct 14, 2020	BUY	$91.64 - $111.29 $9,438 - $11,462	103 Added 3.93%	2,723 $296,000
Q2 2020 Jul 14, 2020	BUY	$76.57 - $98.0 $200,613 - $256,760	2,620 New	2,620 $240,000
Q1 2020 Apr 20, 2020	SELL	$62.82 - $91.86 $206,175 - $301,484	-3,282 Closed	0 $0
Q4 2019 Jan 27, 2020	BUY	$78.51 - $87.4 $257,669 - $286,846	3,282 New	3,282 $285,000

Others Institutions Holding ABT

# of Institutions

3,377

Shares Held

1.33B

Call Options Held

10.6M

Put Options Held

8.72M

View Full List

About ABBOTT LABORATORIES

Ticker ABT
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 1,751,219,968
Market Cap $229B
Description
Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...

More about ABT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Steigerwald, Gordon & Koch Inc., based on Form 13F filings with the SEC.

News

Stay updated on Steigerwald, Gordon & Koch Inc. with notifications on news.

Account

Steigerwald, Gordon & Koch Inc. Abbott Laboratories Transaction History